Stock News & Analysis

This company has a habit of beating the market over long periods.

This biotechnology firm develops precision therapies for rare, genetically defined diseases, with a focus on targeted cancer treatments.

Bristow Group, a global aviation services provider to offshore energy firms, reported a notable insider sale in its latest SEC filing.

Uber is best known for moving people and delivering food. However, something small but potentially profitable is growing at the company.

This clinical-stage biotech develops antibody therapies for thyroid eye disease, advancing multiple candidates through its R&D pipeline.

This clinical-stage biotech develops bladder-sparing therapies for high-risk cancer patients, targeting unmet needs in oncology treatment.

Small modular reactors are shaping up to be one of the biggest trends in nuclear power and BWX Technologies is one of the best ways to play it.

Buffett's actions suggest that we could be knee-deep in investment opportunities soon.

This clinical-stage biotech focuses on targeted cancer therapies and strategic partnerships in oncology and rare disease treatment.

It is a new era at Berkshire Hathaway.

iShares Biotechnology ETF (IBB) gives investors biotech exposure through large, established drug developers rather than smaller speculative names. That structure can offer more earnings visibility, but it also means giving up some upside when risk appetite shifts toward early-stage biotech companies.

While this young and intriguing EV stock has immense upside, it comes with too much risk for many investors -- here's why.

Both companies benefit from the momentum in custom AI chips.

Both stocks provide much more upside than downside at current prices.

Hilton Grand Vacations generates revenue from timeshare sales and financing, but its earnings rise and fall with consumer demand and credit conditions. The extent to which recurring revenue can stabilize financial results is critical to the company’s long-term performance.

Microsoft's valuation is at its lowest point since the 2022 bear market.

Harley-Davidson, a global motorcycle manufacturer, saw an insider sale amid a year of continued business and stock struggles.

These three tech stocks look like long-term winners.

Here's how to participate as the world slowly shifts away from dirtier energy sources and toward cleaner ones.

The social media giant's rapid revenue growth is impressive. But a heavy step-up in planned expenses is raising the stock's risk profile.